close
Add to watchlist
Genoptix Inc (GXDX)
Genoptix, Inc. provides specialized laboratory service that focus on delivering diagnostic services in the United States. Its services include COMPASS service offering, in which the company's hematopathologists determine the appropriate diagnostic tests to be performed, and then integrates patient history and previous and current test results into a comprehensive diagnostic report; and CHART service offering, in which the hematologists and oncologists receives a detailed assessment of a patient's disease progression over time. The company also offers diagnostic services, such as professional interpretation by its hematopathologists. It focuses on marketing its specialized diagnostic services to community-based hematologists and oncologists treating malignancies of the blood and bone marrow, and other forms of cancer. The company was founded in 1999 and is based in Carlsbad, California.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 25.00 |
| Volume | 89024 |
| Volume Avg | 860752 |
| 52 Week High | 39.00 |
| 52 Week Low | 13.51 |
| PE | 19.99 |
| PE (group average) | N/A |
| EPS Year | 1.25 |
| EPS change Q/Q | -21.88% |
| EPS change Q/Q Yr ago | -54.55% |
| EPS change Q/Q next Q est | -3.85% |
| EPS change Y/Y | 29.01% |
| REV change Q/Q | -2.75% |
| REV change Q/Q Yr ago | -2.56% |
| EPS next Q est | 0.26 |
| EPS next Y est | 1.00 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |